Fibrocell and Intrexon's epidermolysis bullosa cell therapy receives U.S. orphan drug status June 17, 2014
Fibrocell and Intrexon contract Progenitor Cell Therapy to produce epidermolysis bullosa therapy June 2, 2014
RSS